Coronary flow reserve is reduced in young men with IDDM

Diabetes

Volumn 47, Issue 2, 1998, Pages 248-254

  Pitkänen, Olli Pekka ^a,e   Nuutila, Pirjo ^a   Raitakari, Olli T ^a   Rönnemaa, Tapani ^a   Koskinen, Pertti J ^a   Iida, Hidehiro ^d   Lehtimäki, Terho J ^b,c   Laine, Hanna K ^a,c   Takala, Teemu ^b   Viikari, Jorma S A ^a   Knuuti, Juhani ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^d RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 2642626653     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.2.248     Document Type: Article

References (49)

1. Krolewski S, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750-755, 1987
2. Donahue RP, Orchard TJ: Diabetes mellitus and macrovascular complications: an epidemiological perspective. Diabetes Care 15:1141-1155, 1992
3. Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B, the EURODIAB IDDM Complications Study Group: Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care 19:689-697, 1996
4. Fisher BM, Gillen G, Lindop GBM, Dargie HJ, Frier BM: Cardiac function and coronary arteriography in asymptomatic type 1 (insulin-dependent) diabetic patients: evidence for a specific diabetic heart disease. Diabetologia 29:706-712, 1986
5. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA: Impaired endothelium-dependent vasodilatation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510-2516, 1993
6. Calver AC, Collier JG, Vallance PJT: Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:2548-2554, 1992
7. Kool MJ, Lambert J, Stehouwer CD, Hoeks AP, Boudier HAS, Van Bortel LM: Vessel wall properties of large arteries in uncomplicated IDDM. Diabetes Care 18:618-624, 1995
8. Nitenberg A, Valensi P, Sachs R, Dali M, Aptecar E, Attali J-R: Impairment of coronary vascular reserve and ACh-induced coronary vasodilatation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42:1017-1025, 1993
9. Nahser PJ, Brown RE, Oskarsson H, Winniford MD, Rossen JD: Maximal coronary flow reserve and metabolic coronary vasodilatation in patients with diabetes mellitus. Circulation 91:635-640, 1995
10. 15O. Circulation 70:724-733, 1984
11. Krivokapich J, Smith GT, Huang SC, Hoffman EJ, Ratib O, Phelps ME, Schelbert HR: Nitrogen-13 ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 80:1328-1337, 1989
12. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE: Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 15:1032-1042, 1990
13. Araujo LI, Lammertsma AA, Rhodes CG, McFalls EO, liida H, Rechavia E, Galassi A, De-Silva R, Jones T, Maseri A: Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 83:875-885, 1991
14. Leipert B, Becker BF, Gerlach E: Different endothelial mechanisms involved in coronary respoases to known vasodilators. Am J Physiol 262:H1676-H1683, 1992
15. Mayhan WG: Endothelium-dependent responses of cerebral arterioles to adenosine 5′-diphosphate. J Vasc Res 29:353-358, 1992
16. Lupi A, Buffon A, Finocchiaro ML, Conti E, Maseri A, Crea F: Mechanisms of adenosine-induced epicardial coronary artery dilatation. Eur Heart J 18:614-617, 1997
17. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
18. Clark J, Crouzel C, Meyer G, Strijckmans K: Current methodology for oxygen-15 production for clinical use. Appl Radiat Isot 38:597-600, 1987
19. Crouzel C, Clark J, Brihaye C, Långström O, Lemaire C, Meyer G, Nebeling B, Stone-Elander S: Radiochemistry automation for PET. In Radiopharmaceuticals for Positron Emission Tomography. Stocklin G, Pike V, Eds. The Netherlands, Kluwer Academic Publishers, 1993, p 45-90
20. 15O and dynamic positron-emission tomography: strategy for quantification in relation to the partial-volume effect. Circulation 78:104-115, 1988
21. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma A: Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 36:78-85, 1995
22. Iida H, Rhodes C, de Silva R, Araujo LI, Bloomfleld PM, Lammertsma AA, Jones T: Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 33:1669-1677, 1992
23. Piha, SJ: Cardiovascular autonomic function tests. Normal responses and determination of reference values. Clin Physiol 11:277-290, 1991
24. Kadish A, Little R, Sternberg J: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116-131, 1968
25. Viikari J: Precipitation of plasma lipoproteins by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand J Clin Lab Invest 36:265-268, 1976
26. Friedewald WT, Levy R, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
27. Heitzer T, Ylä-Herttuala S, Luoma J, Kurz S, Munzel T, Just H, Olschewski M, Drexler H: Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL. Circulation 93:1346-1353, 1996
28. Flier JS, Underhill LH: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321, 1988
29. Vlassara H: Advanced glycation end-products and atherosclerosis. Ann Med 28:419-426, 1996
30. Garcia MJ, McNamara PM, Gordon T, Kannell WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23:105-111, 1974
31. Kannel WB, McGee DL: Diabetes and cardiovascular disease: The Framingham Study. JAMA 241:2035-2038, 1979
32. Singer DE, Nathan DM, Anderson KM, Wilson PWF, Evans JC: Association of HbAlc with prevalent cardiovascular disease in the original cohort of The Framingham Heart Study. Diabetes 41:202-208, 1992
33. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M: Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 46:1354-1359, 1997
34. Bao W, Srinivasan SR, Berenson GS: Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. Circulation 93:54-59, 1996
35. Howard BV: Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987
36. Ginsberg HN: Lipoprotein physiology in nondiabetic and diabetic states: relationship to atherogenesis. Diabetes Care 14:839-855, 1991
37. Taskinen M-R. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41 (Suppl. 2):12-17, 1992
38. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
39. Yudkin JS: Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis. J Intern Med 238:21-30, 1995
40. Mäkimattila S, Mäntysaari M, Groop P-H, Summanen P, Virkamäki A, Schlenzka A, Fagerudd J, Yki-Järvinen H: Hyperreactivity to nitrovasodilatators in forearm vasculature is related to autonomie dysfynction in insulin-dependent diabetes mellitus. Circulation 95:618-625, 1997
41. Fuller JH, Keen H, Jarrett RJ: Hemostatic variables associated with diabetes mellitus and its complications. Br Med J 2:964-966, 1979
42. Winocour P: Platelet abnormalities in diabetes mellitus. Diabetes 41 (Suppl. 2):67-73, 1992
43. Kwaan HC: Changes in blood coagulation, platelet function, and plasminogenplasmin system in diabetes. Diabetes 41 (Suppl. 2):32-35, 1992
44. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
45. Stout RW: Overview of the association between insulin and atheroslerosis. Metabolism 34:7-12, 1985
46. Stolar MW: Atherosclerosis in diabetes: the role of hyperinsulinemia. Metabolism 37:1-9, 1988
47. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G: PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 43:426-429, 1994
48. King GL, Oliver J, Inoguchi T, Shiba T, Banskota K: Abnormalities of the vascular endothelium in diabetes. In The Diabetes Annual. Marshall SM, Home PD, Alberti KGMM, Krall LP, Eds. Amsterdam, Elsevier Science, 1993, p. 107-126
49. Rubanyi G, Romero J, Vanhoutte P: Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 240:H767-H774, 1986